AnteoTech : Presentation Canaccord Genuity Battery Technology Conference

For personal use only

ASX Announcement

7 December 2021

Presentation at Canaccord Genuity

Battery Technology Conference

AnteoTech Ltd (ASX: ADO) ("AnteoTech" or "the Company") is pleased to announce its participation at today's Canaccord Genuity Inaugural "Charging Up" Battery Technology Conference.

CEO Derek Thomson and Head of Energy, Manuel Wieser will present an overview of the Company's progress towards developing a silicon anode.

The Canaccord Genuity "Charging Up" Battery Technology Conference, is a virtual event hosted by Canaccord for its clients.

A copy of the presentation is attached.

This announcement has been authorised for release by the Board.

For more information, please contact:

Friederike Graser, Communications Manager, AnteoTech Ltd: [phone]

Ben Jarvis, Six Degrees Investor Relations: [phone]

About AnteoTech - (ASX:ADO)

AnteoTech is a surface chemistry company with Intellectual Property ("IP") in its core technology product groups AnteoCoat™, AnteoBind™ and AnteoRelease™. The Company's purpose is to create shareholder value by identifying and solving important global industry problems by providing unique value-add solutions for its customers. Customers operate in the life sciences, diagnostics, energy and medical devices markets.

AnteoTech - Social Media Policy

AnteoTech is committed to communicating with the investment community through all available channels. Whilst ASX remains the prime channel for market sensitive news, investors and other interested parties are encouraged to follow AnteoTech on Twitter (@AnteoTech_), LinkedIn.

Subscribe to AnteoTech Latest News emails - visit our website at www.anteotech.com and subscribe to receive Lates News bulletin, our email alert service.

AnteoTech Ltd	T [phone]
ACN 070 028 625	E [e-mail]
Unit 4, 26 Brandl Street, Eight Mile Plains, QLD, 4113	anteotech.com
Australia

ersonal use only

Our Silicon Anode Roadmap

Canaccord Genuity - Inaugural "Charging Up" Battery Technology Conference

07 December 2021

AnteoTech Ltd (ASX:ADO)

Presenters:

Derek Thomson, CEO

Manuel Wieser, Head of Energy

DISCLAIMER

ersonal use only

Important Information

The purpose of the presentation is to provide an update of the business of AnteoTech Ltd (ASX:ADO) (AnteoTech). These slides have been prepared as a presentation aid only and the information they contain may require further explanation and/or clarification. Accordingly, these slides and the information they contain should be read in conjunction with past and future announcements made by AnteoTech and should not be relied upon as an independent source of information. Please contact AnteoTech and/or refer to the Company's website for further information.

The views expressed in this presentation contain information derived from publicly available sources that have not been independently verified. No representation or warranty is made as to the accuracy, completeness or reliability of the information.

Forward-looking statements

The presentation may contain certain "forward-looking statements". Forward-looking statements can generally be identified by the use of forward-looking words such as "may", "will", "would", "could", "expect", "intend", "plan", "aim", "estimate", "target", "anticipate", "believe", "continue", "objectives", "outlook", "guidance" or other similar words, and include statements regarding AnteoTech's intent, belief or current expectations with respect to AnteoTech's business and operations, market conditions, results of operations and financial condition, capital adequacy and risk management. These forward looking statements should not be relied upon as a representation or warranty, express or implied, as to future matters. Prospective financial information has been based on current expectations about future events and is, however, subject to risks, uncertainties, contingencies and assumptions that could cause actual results to differ materially from the expectations described in such prospective information. AnteoTech disclaims any obligation to update any forward looking statement to reflect events or circumstances after the date of the presentation, subject to the disclosure requirements applicable to the Group.

Not an offer of securities

This presentation should not be relied on as a recommendation or forecast by AnteoTech Nothing in this presentation should be construed as either an offer to sell or a solicitation of an offer to buy or sell shares in any jurisdiction. The information in this presentation is not intended to be relied upon as advice to investors or potential investors and does not take into account your financial objectives, situation or needs. Investors should consult with their own legal, tax, business and/or financial advisors in connection with any investment decision

EuGeni SARS-CoV-2 Ag RDT - CE Marked - not available in other jurisdictions

• The COVID-19 rapid antigen test (RAT) must not be supplied for the purpose of self-testing
• The COVID-19 rapid antigen test must only be used by relevant practitioners, or persons under their supervision, who are trained in the correct use of the goods and the interpretation of the test results
• Negative test results do not exclude infection with COVID-19 (so face masks, social distancing and good hygiene practice must be maintained)
• Positive test results or symptomatic persons require immediate confirmatory testing with a polymerase chain reaction (PCR) test.

7 December 2021

ersonal use only

ANTEOTECH - TODAY

AnteoTech is commercialising innovative patented technology - with revenue opportunity across two key growth sectors: Point of Care (POC) diagnostics and Lithium-ion battery market

	Unique, proprietary nano-polymer technology
	• Proven product AnteoBind in market		SHARE PRICE & VOLUME (DECEMBER 2020 - DECEMBER 2021)
STRONG IP	•	Strong IP position across Life Science & Energy applications	0.5		100
POSITION
			0.45		90
	Developing solutions in high growth, high impact sectors	0.4		80
	•	Improving Point-Of-Care(POC) testing & assay	0.35		70
		development in diagnostics, drug development	0.3		60	Millions
SECTORS			0.2		40
HIGH IMPACT	•	Improving Li-ion battery energy storage as a result of enhanced	0.25		50
$
		silicon integration - AnteoX, AnteoLink
			0.15		30
			0.1		20
		Active in Growth markets	0.05		10
GROWTH	• Life Science - Lateral Flow Assay market grow to US$11.5b by 2036	0		0
•	Energy - Lithium battery market growing to US$ 470 B by 20302
MARKETS
	Ready to deliver - short to medium term opportunity		Volume	Close

• Life Science - Growing distribution network and pipeline of tests.
• Energy - strong network of collaborators spanning battery value chain

1.Source: Market Forecast:Lateral Flow Assay Market - Growth, Trends,COVID-19

Impact, and Forecasts (2021 - 2026)Mordor Intelligence

2. Source: International Energy Agency World Energy Outlook Net Zero emission scenario 2021

3

OUR ENERGY STORY IS ABOUT CAPABILITY AND IP

ersonal use only

Industry leading approach that uses micro-silicon in a full cell design allowing for stable cycling of high silicon content anodes.

Anode design that is easily tunable to cater for the industry's future anode targets over the coming decade and beyond of 600mAh/g to 1000mAh/g.

In-depth coating formulation know-how that integrates silicon into anode designs and corresponding database or results for efficient benchmarking of design iterations.

In-house capability from slurry processing to electrode coating and battery assembly.

Knowledge pool spanning various silicon chemistries, electrolyte formulations, performance enhancing processes & electrochemical testing.

Strong existing industry engagement with potential customers and commercial partners plus lead role in $135M Australian Future Battery Industries CRC.

4